The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1

Maria Nilsson1, Sylwia Wasylik, Matthias Mörgelin

  • 1Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden. maria_e.nilsson@hotmail.com

Molecular Microbiology
|December 21, 2007
PubMed

Insights

Antibacterial peptides from beta-2 glycoprotein I fight bacteria. However, Streptococcus pyogenes uses surface proteins H and M1 to block these peptides, evading the immune response.

Area of Science:

  • Biochemistry
  • Immunology
  • Microbiology

Background:

  • Antibacterial peptides are crucial for innate immunity.
  • Beta-2 glycoprotein I (beta(2)GPI) is a human plasma protein with potential antibacterial properties.
  • Streptococcus pyogenes is a significant human pathogen that employs sophisticated evasion strategies.

Purpose of the Study:

  • To investigate the antibacterial activity of beta(2)GPI-derived peptides.
  • To elucidate the mechanisms by which Streptococcus pyogenes evades attacks by these peptides.

Main Methods:

  • Analysis of antibacterial activity of beta(2)GPI peptides against Gram-positive and Gram-negative bacteria.
  • Investigation of the interaction between S. pyogenes surface proteins (H and M1) and beta(2)GPI.
  • Assessment of the role of S. pyogenes proteins in inhibiting beta(2)GPI processing and peptide activity.

Main Results:

  • Peptides derived from beta(2)GPI exhibit antibacterial activity.
  • Streptococcus pyogenes proteins H and M1 bind to beta(2)GPI, preventing its cleavage into antibacterial peptides by neutrophil proteases.
  • These streptococcal proteins also bind and inhibit the activity of beta(2)GPI-derived antibacterial peptides.

Conclusions:

  • Streptococcal proteins H and M1 provide a novel resistance mechanism against beta(2)GPI-derived antibacterial peptides.
  • This interaction highlights a sophisticated immune evasion strategy employed by S. pyogenes.
  • Understanding this interaction could lead to new therapeutic approaches against bacterial infections.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...